Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
Clinical trial NCT03529422 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03529422
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-07
- Primary completion
- 2024-07-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.